Ensembl specifications


Unique identifier OMICS_01647
Name Ensembl
Restrictions to use None
Database management system MySQL
Community driven No
Data access File download, Browse, Application programming interface
User data submission Not allowed
Maintained Yes


  • person_outline Paul Flicek

Publications for Ensembl


Ensembl 2019

2019 Nucleic Acids Res
PMCID: 6323964
PMID: 30407521
DOI: 10.1093/nar/gky1113

Ensembl 2018

2018 Nucleic Acids Res
PMCID: 5753206
PMID: 29155950
DOI: 10.1093/nar/gkx1098

Ensembl 2017

2017 Nucleic Acids Res
PMCID: 5210575
PMID: 27899575
DOI: 10.1093/nar/gkw1104

Ensembl 2016

2016 Nucleic Acids Res
PMCID: 4702834
PMID: 26687719
DOI: 10.1093/nar/gkv1157

Ensembl 2015

2015 Nucleic Acids Res
PMCID: 4383879
PMID: 25352552
DOI: 10.1093/nar/gku1010

Ensembl 2014

2014 Nucleic Acids Res
PMCID: 3964975
PMID: 24316576
DOI: 10.1093/nar/gkt1196

Ensembl 2013

2013 Nucleic Acids Res
PMCID: 3531136
PMID: 23203987
DOI: 10.1093/nar/gks1236

Ensembl 2012

2012 Nucleic Acids Res
PMCID: 3245178
PMID: 22086963
DOI: 10.1093/nar/gkr991

Ensembl 2011

2011 Nucleic Acids Res
PMCID: 3013672
PMID: 21045057
DOI: 10.1093/nar/gkq1064

Ensembl 2009

2009 Nucleic Acids Res
PMCID: 2686571
PMID: 19033362
DOI: 10.1093/nar/gkn828

Ensembl 2008

2008 Nucleic Acids Res
PMCID: 2238821
PMID: 18000006
DOI: 10.1093/nar/gkm988

Ensembl 2007

2007 Nucleic Acids Res
PMCID: 1761443
PMID: 17148474
DOI: 10.1093/nar/gkl996

Ensembl 2006

2006 Nucleic Acids Res
PMCID: 1347495
PMID: 16381931
DOI: 10.1093/nar/gkj133

Ensembl 2005

2005 Nucleic Acids Res
PMCID: 540092
PMID: 15608235
DOI: 10.1093/nar/gki138

Ensembl 2004.

2004 Nucleic Acids Res
PMCID: 308772
PMID: 14681459
DOI: 10.1093/nar/gkh038
Ensembl institution(s)
European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK; Eagle Genomics Ltd., Wellcome Genome Campus, Hinxton, UK; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, UK
Ensembl funding source(s)
Supported by the Wellcome Trust [WT108749/Z/15/Z] with additional funding for specific project components from the National Human Genome Research Institute of the National Institutes of Health [2U41HG007234, U41HG007823]; by the Biotechnology and Biological Sciences Research Council [BB/N019563/1, BB/M011615/1]; Open Targets; Wellcome Trust [WT108749/Z/15/A, WT104947/Z/14/Z, WT200990/Z/16/Z, WT201535/Z/16/Z]; ELIXIR, the research infrastructure for life-science data; Save the Tasmanian Devil Program; and the European Molecular Biology Laboratory; the European Union’s Horizon 2020 research and innovation programme [634143] (MedBioinformatics). This project has received funding from the European Union’s Horizon 2020 research and innovation programme [733161] (MultipleMS). This project has received support from the Innovative Medicines Initiative Joint Undertaking [115582] (EBISC), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies’ inkind contribution

Ensembl reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review Ensembl